| Pharmaceutical active ingredients: |
| Zanamivir |
| Available forms, composition and doses of Relenza: |
| Powder; Inhalation; Oral; Zanamivir 5 mg |
| Relenza medical category: |
| Human:AntiviralsNeuraminidase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AH01 - Zanamivir |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineFirma Chun CheongZuellig Pharma |
| Related documents and information about Relenza: |
| Relenza prescribing information (PDF) |